Agenus (AGEN) News Today $4.60 +0.22 (+5.02%) Closing price 04:00 PM EasternExtended Trading$4.59 -0.01 (-0.22%) As of 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Agenus' (AGEN) Buy Rating Reiterated at HC WainwrightSeptember 12, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Agenus (NASDAQ:AGEN)September 12, 2025 | americanbankingnews.comAgenus’s Strategic Advances in Oncology: Buy Rating Affirmed by Emily BodnarSeptember 10, 2025 | tipranks.comFrance Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal CancerSeptember 9, 2025 | financialpost.comFFrance Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal CancerSeptember 9, 2025 | businesswire.comAgenus to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 5, 2025 | businesswire.comSiren L.L.C. Acquires New Position in Agenus Inc. $AGENAugust 31, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Given Buy Rating at HC WainwrightAugust 30, 2025 | marketbeat.comAgenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)August 28, 2025 | seekingalpha.comAgenus Receives Buy Rating: Promising Clinical Trials and Strategic Partnerships Drive Growth PotentialAugust 28, 2025 | tipranks.comAgenus (NASDAQ:AGEN) Stock Crosses Above 200-Day Moving Average - Should You Sell?August 28, 2025 | marketbeat.comGlobal Digital Biomarkers Market Anticipating Remarkable Growth at a CAGR of ~17% by 2032 | DelveInsightAugust 26, 2025 | finance.yahoo.comWhat To Expect From Agenus Inc (AGEN) Q2 2025 EarningsAugust 26, 2025 | finance.yahoo.comUpdate: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK SpotlightAugust 26, 2025 | mms.businesswire.comUpdate: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK SpotlightAugust 26, 2025 | businesswire.comPD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsightAugust 19, 2025 | finance.yahoo.comAgenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025August 19, 2025 | businesswire.comAgenus (NASDAQ:AGEN) Cut to Hold at Wall Street ZenAugust 18, 2025 | marketbeat.comWilliam Blair Forecasts Agenus' Q3 Earnings (NASDAQ:AGEN)August 17, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Rating Increased to Hold at Zacks ResearchAugust 17, 2025 | marketbeat.comHC Wainwright Predicts Agenus' Q3 Earnings (NASDAQ:AGEN)August 16, 2025 | marketbeat.comZydus Life beats Street in Q1, eyes biosimilars boost in USAugust 14, 2025 | msn.comAgenus Inc. Faces Ongoing Risks: What Investors Need to KnowAugust 13, 2025 | msn.comAgenus Inc Reports Q2 2025 Earnings: EPS Loss of $2.03, Revenue at $25.7 Million, Missing EstimatesAugust 13, 2025 | gurufocus.comAgenus (NASDAQ:AGEN) Posts Quarterly Earnings Results, Misses Estimates By $0.22 EPSAugust 12, 2025 | marketbeat.comAgenus: Cash Starved Pharma Counting On Bot/Bal Cancer BountyAugust 12, 2025 | seekingalpha.comAgenus: Hold Rating Amid Partnership Gains and Clinical Trial ChallengesAugust 12, 2025 | tipranks.comAgenus Inc. Reports Q2 2025 Financial ResultsAugust 11, 2025 | tipranks.comAgenus: Q2 Earnings SnapshotAugust 11, 2025 | finance.yahoo.comAgenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic ProgressAugust 11, 2025 | businesswire.comAgenus (NASDAQ:AGEN) Upgraded to Buy at Wall Street ZenAugust 10, 2025 | marketbeat.comExamining the Future: Agenus's Earnings OutlookAugust 8, 2025 | benzinga.comAgenus (NASDAQ:AGEN) Shares Cross Above 200 Day Moving Average - Here's WhyAugust 8, 2025 | marketbeat.comAgenus (AGEN) to Release Earnings on MondayAugust 5, 2025 | marketbeat.comZacks.com featured highlights include QuantumScape, Civeo and AgenusAugust 1, 2025 | finance.yahoo.comAgenus to Provide Corporate Update and Second Quarter 2025 Financial Report | AGEN Stock NewsJuly 31, 2025 | gurufocus.comAgenus to Provide Corporate Update and Second Quarter 2025 Financial ReportJuly 31, 2025 | businesswire.comAgenus (NASDAQ:AGEN) Shares Cross Above 200 Day Moving Average - Time to Sell?July 30, 2025 | marketbeat.comAgenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025July 25, 2025 | businesswire.comAgenus (NASDAQ:AGEN) Stock Passes Above 200 Day Moving Average - Here's What HappenedJuly 22, 2025 | marketbeat.comMiNK Therapeutics, Inc.'s (NASDAQ:INKT) biggest owners are public companies who got richer after stock soared 815% last weekJuly 14, 2025 | finance.yahoo.comAgenus (NASDAQ:AGEN) Share Price Crosses Above 200-Day Moving Average - Here's WhyJuly 12, 2025 | marketbeat.comAgenus unit, MiNK surges after peer-reviewed data for lead drugJuly 11, 2025 | seekingalpha.comZacks.com featured highlights Yext, Agenus and NCR VoyixJuly 10, 2025 | finance.yahoo.comWilliam Blair Reaffirms Their Hold Rating on Agenus (AGEN)July 9, 2025 | theglobeandmail.comAgenus’s Strategic Advancements and Promising Clinical Data Boost Investor ConfidenceJuly 8, 2025 | tipranks.comAgenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3July 7, 2025 | finance.yahoo.comAgenus' BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3July 7, 2025 | businesswire.comAgenus Inc. (NASDAQ:AGEN) Given Average Rating of "Hold" by AnalystsJuly 4, 2025 | marketbeat.comAgenus (NASDAQ:AGEN) Share Price Crosses Above 200 Day Moving Average - Time to Sell?June 24, 2025 | marketbeat.com Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AGEN Media Mentions By Week AGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGEN News Sentiment▼0.000.73▲Average Medical News Sentiment AGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGEN Articles This Week▼06▲AGEN Articles Average Week Get the Latest News and Ratings for AGEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Agenus and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies XOMA Royalty News Emergent Biosolutions News Lexicon Pharmaceuticals News Vanda Pharmaceuticals News Crescent Biopharma News Codexis News Ironwood Pharmaceuticals News Achieve Life Sciences News Sangamo Therapeutics News Fortress Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGEN) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agenus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agenus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGEN Stock Alerts